Position in LNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$69,870,677
-$4,023,151 QoQ
Shares Held
629,806
-35.4% QoQ
Ownership
0.965%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#30
of 462 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Derivatives in LNTH
reported options exposure · as of Jun 30, 2026CallValue
$554,700
CallShares
5,000
PutValue
$44,376
PutShares
400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names. LNTH ranks #3 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
201,159 | $108,993,980 | |
| 2 | HLN |
Haleon plc
|
9,264,255 | $86,435,499 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
This page
|
629,806 | $69,870,677 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,250,639 | $51,313,718 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
659,493 | $42,174,577 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,059,778 | $35,905,278 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
2,235,821 | $11,022,597 | |
| 8 | EOLS |
Evolus, Inc.
|
1,508,518 | $10,469,114 |
All Filings in LNTH
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $554,700 | 5,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $44,376 | 400 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $69,870,677 | 629,806 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $386,835 | 5,100 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $73,893,828 | 974,210 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $67,506,256 | 1,014,369 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $1,504,030 | 22,600 | Call | Defined | 2026-02-17 | |
| 2024-09-30 | $1,911,954 | 17,421 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,794,057 | 333,716 | Shares | Defined | 2024-09-16 | |
| 2023-12-31 | $6,200,000 | 100,000 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $7,665,556 | 123,638 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $42,881,994 | 519,404 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $28,042,166 | 550,278 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $42,345,765 | 641,311 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $50,483,040 | 912,729 | Shares | Defined | 2022-05-16 | |
| 2021-06-30 | $10,136,030 | 366,716 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||